QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip M Arlen, MD
Precision Biologics, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Pacific Medical Center
San Francisco, California, United States
- Smilow Cancer Hospital- Yale
New Haven, Connecticut, United States
- University of Miami
Miami, Florida, United States
- National Cancer Institute
Bethesda, Maryland, United States
- Beht Isreal Deaconess Medical Center
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 13 Mar 2017
- Completion
- 31 Dec 2019
- Last update posted
- 7 May 2025
- Registered enrollment
- 81
- Registry id
- NCT01834235
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.